Mike Fratantoro - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Mike Fratantoro's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Mike Fratantoro
Verified
Chief Editor, RT Magazine
Los Angeles
Beats
in vitro diagnostics oncology and personalized medicineGenetics and genomics research
Content
By Mike Fratantoro Verified| respiratory-therapy.com@ E-cigarettes and COPD: Exclusive e-cigarette use is significantly associated with an increased risk of chronic obstructive pulmonary disease (COPD), although the risk is lower than that posed by traditional cigarettes. Potential Cardiovascular Impact: While no strong link was found between exclusive e-cigarette use and major cardiovascular events like heart failure or type 2 diabetes, a slight increase in hypertension risk was observed in adults aged 30–70.
By Mike Fratantoro Verified| respiratory-therapy.com@ UCLA-led research found that Paxlovid does not significantly reduce COVID-19 hospitalizations or deaths among vaccinated older adults, contradicting earlier findings in unvaccinated populations. The study leveraged a natural experiment in Ontario, Canada, where Paxlovid prescriptions doubled at age 70 but showed no impact on hospitalization or mortality outcomes.
By Mike Fratantoro Verified| respiratory-therapy.com@ E-cigarettes and COPD: Exclusive e-cigarette use is significantly associated with an increased risk of chronic obstructive pulmonary disease (COPD), although the risk is lower than that posed by traditional cigarettes. Potential Cardiovascular Impact: While no strong link was found between exclusive e-cigarette use and major cardiovascular events like heart failure or type 2 diabetes, a slight increase in hypertension risk was observed in adults aged 30–70.
Company Info
RT Magazine
Clinical Lab Products (CLP), under the MEDQOR brand, is a dedicated media platform for the clinical laboratory industry. It provides valuable resources for professionals by offering comprehensive coverage of diagnostic technologies, product innovations, and industry trends. CLP delivers editorial content through monthly print magazines and e-newsletters that analyze product developments and best practices. It also features a Resource Center with webinars and expert discussions on relevant topics, such as Anti-Xa assay testing. The platform reaches over 40,000 decision-makers, including pathologists, lab managers, and technologists, ensuring that its content supports informed decision-making in clinical laboratories. As part of MEDQOR’s Clinical Laboratory Division, CLP collaborates with industry experts to maintain its position as a leading source of news and insights in clinical lab technology.
Los Angeles, United States
+1 310-642-4400